Product Information

TACROLIMUS 0.1% OINTMENT is a generic product labeled by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., priced at $0.9560 per GM under NDC 00168041630. Its NADAC has been published 601 times since Feb 18, 2015.

FDA first approved this application on Sep 9, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TACROLIMUS 0.1% OINTMENT

tacrolimus
$0.9560per GM

Strength

1 mg/g

NDC

00168041630

Classification

Generic

Dosage Form

OINTMENT

Route

TOPICAL

Effective Date

8/19/2026

Active Ingredients

TACROLIMUS

Approval Type

Generic (ANDA)

FDA Application

ANDA200744

FDA Approved

9/9/2014

TE Code

AB

On Market Since

9/9/2014

Pharmacological Classes

Price Statistics

The NADAC for TACROLIMUS 0.1% OINTMENT has been published 601 times since Feb 18, 2015, and over the history we have for it it has declined 85.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9560 per GM
All-time high$6.4762 (Apr 15, 2015)
All-time low$0.7143 (Nov 20, 2024)
52-week high$1.0368
52-week low$0.9245
Median price$3.1312
Average price$3.2881
Largest weekly change+41.4% (Aug 21, 2024)
Weeks tracked601
Tracking sinceFeb 18, 2015

Price History

1W

-0.8%

1M

-0.8%

3M

-3.7%

6M

+1.1%

1Y

-7.8%

3Y

-36.7%

5Y

-60.3%

All

-85.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TACROLIMUS 0.1% OINTMENT?

The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 0.1% OINTMENT, manufactured by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., is $0.9560 per GM (NDC 00168041630), effective Aug 19, 2026.

How has the price of TACROLIMUS 0.1% OINTMENT changed over time?

Over the history we have for it, the NADAC for TACROLIMUS 0.1% OINTMENT has declined 85.2%. It has been tracked across 601 weekly CMS publications since Feb 18, 2015.

What are the highest and lowest recorded NADAC prices for TACROLIMUS 0.1% OINTMENT?

Since Feb 18, 2015, the NADAC for TACROLIMUS 0.1% OINTMENT has ranged from a low of $0.7143 (Nov 20, 2024) to a high of $6.4762 (Apr 15, 2015), with a median of $3.1312 per GM.

Are there cheaper alternatives to TACROLIMUS 0.1% OINTMENT?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TACROLIMUS 0.1% OINTMENT, is $0.9192 per GM — about 4% below TACROLIMUS 0.1% OINTMENT.

Who manufactures TACROLIMUS 0.1% OINTMENT?

TACROLIMUS 0.1% OINTMENT (NDC 00168041630) is labeled by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., and CMS classifies it as a generic product.